Revolutionary Gene Therapy Restores Sight for a 6-Year-Old Girl

In a remarkable medical breakthrough, a 6-year-old girl from the UK, Saffie Sandford, has regained her ability to see in both daylight and at night, thanks to an innovative one-time gene therapy developed for a rare genetic condition known as Leber’s Congenital Amaurosis (LCA). This condition typically leads to severe visual impairment from an early age, but Saffie's story provides hope for many.

Transformative Treatment at Great Ormond Street Hospital

Diagnosed with LCA, Saffie was unable to see properly due to a mutation in the RPE 65 gene, which affected her vision in low light and even during the day. Fortunately, by the time Saffie was referred to Great Ormond Street Hospital (GOSH), advancements in gene therapy had paved the way for an effective treatment. Luxturna, the gene therapy used, introduces a healthy version of the RPE 65 gene directly into the eyes in a single administration.

A Life-Changing Experience for Saffie and Her Family

Saffie received her first dose of Luxturna in April 2025, followed by a second dose in September. Her mother, Lisa, described the impact of this treatment as “life-changing,” stating, “It’s like someone waved a magic wand and restored her sight in the dark.” The family can now enjoy outings they once thought impossible, such as trick or treating and dining out in the evening—a significant change from their previous experiences.

Encouraging Outcomes and Future Implications

The success of Saffie's treatment reflects broader trends observed in clinical trials conducted by GOSH and Moorfields Eye Hospital. Recent studies demonstrated that 7 out of 10 children treated with Luxturna experienced meaningful improvements in vision. These results suggest that gene therapy could serve as a viable treatment option for many children suffering from LCA and potentially other similar visual impairments.

Rob Henderson, a consultant ophthalmologist at GOSH, highlighted the significance of these findings, stating, “For many of the families we work with, even small improvements in their child’s ability to see the world around them make a profound difference.” As research continues, the potential for gene therapies not only for vision but also for hearing disorders reinforces the ongoing progress in medical science.